newsfilter
← Latest News
PR Newswire·

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...